Skip to main content
Log in

Cell-mediated cytotoxicity in glioma-bearing patients: Differential responses of peripheral blood mononuclear cells to stimulation with interleukin-2 and microbial antigen

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Peripheral blood mononuclear cells (PBMC) of malignant glioma-bearing patients were stimulated in vitro with Interleukin-2 (ILr2) or a glucomannan-protein antigen of Candida albicans (GMP) then assayed for proliferation, production of IFN-gamma, and generation of cytotoxic effectors against either K562 tumor cell line or freshly-cultured allogenic glioma cells. PBMC of healthy, age and sex-matched subjects were the controls. PBMC of glioma-bearing patients did not differ, as a whole, from PBMC of healthy donors in IL-2 or GMP-induced proliferation. However, they showed a lesser ability to produce IFN as well as a substantial inability to generate cytotoxic effectors following GMP stimulation. PBMC of glioma patients were fully responsive to ILr2 in cytotoxicity generation, as were the PBMC from normal subjects. The results suggest that glioma patients may have a defective antigen-mediated activation of natural cytotoxic effectors. This hyporesponsiveness is not accompanied by depressed lymphoproliferation and does not apparently involve a reduced response to IL-2.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ommaya AK: Immunotherapy of gliomas: a review. Adv Neurol 15:337–354, 1986

    Google Scholar 

  2. Terry WD, Rosemberg SA (eds): Immunotherapy of human cancer. Elsevier/North-Holland, New York, 1982

    Google Scholar 

  3. Brooks WH, Caldwell HD, Mortara RH: Immune responses in patients with glioma. Surg Neurol 2:419–423, 1974

    Google Scholar 

  4. Mahaley MS, Brooks WH, Roszman TL, Bigner DD, Dudka L, Richardson S: Immunobiology of primary intracranial tumors. Part I: Studies of cellular and Immoral general immune competence of brain-tumor patients. J Neurosurg 44:467–479, 1977

    Google Scholar 

  5. Blomgren H, Blom U, Ullen H: Relation between the site of primary intracranial tumors and mitogenic responses of blood lymphocytes. Cancer Immunol Immunother 21:31–38, 1986

    Google Scholar 

  6. Roszman TL, Brooks WH, Elliott LH: Immunobiology of primary intracranial tumors. VI Suppressor cell function and lectin-binding lymphocyte subpopulations in patients with cerebral tumors. Cancer 50:1273–1279, 1982

    Google Scholar 

  7. Brooks WH, Netsky MG, Normansell DE, Horwitz DA: Depressed cell-mediated immunity in patients with primary intracranial tumors. J Exp Med 136:1631–1647, 1972

    Article  CAS  PubMed  Google Scholar 

  8. Neuwelt EA, Kikuchi K, Hill S, Lipsky P, Frenkel EP: Immune responses in patients with brain tumors: factors such as anticonvulsants that may contribute to impaired cell-mediated immunity. Cancer 51:248–255, 1983

    Google Scholar 

  9. Rosemberg S: Lymphokine-activated killer cells: a new approach to immunotherapy of cancer. JNCI 75:595–603, 1985

    Google Scholar 

  10. Jacobs SK, Wilson DJ, Kornblith PL, Grimm EA: In vitro killing of human glioblastoma by interleukin-2-activated autologous lymphocytes. J Neurosurg 64:114–117, 1986

    Google Scholar 

  11. Jacobs SK, Wilson DJ, Kornblith PL, Grimm EA: Interleukin-2 and autologous lymphokine-activated killer cells in the treatment of malignant glioma. J Neurosurg 64:743–749, 1986

    Google Scholar 

  12. Ausiello C, Spagnoli GC, Boccanera M, Casalinuovo I, Malavasi F, Casciani CU, Cassone A: Proliferation of human peripheral blood mononuclear cells induced by Candida albicans and its cell wall fractions. J Med Microbiol 22:195–202, 1986

    Google Scholar 

  13. Spagnoli GC, Ausiello C, Casalinuovo I, Antonelli G, Dianzani F, Cassone A: Candida albicans and a phosphorylated glucomannan-protein fraction of its cell wall induce production of immune interferon by human peripheral blood mononuclear cells. IRCS Med Sci 13:1190–1191, 1985

    Google Scholar 

  14. Ausiello C, Spagnoli GC, Antonelli G, Malavasi F, Dianzani F, Casciani CU, Cassone A: Generation and characterization of cytotoxic activity against tumor cells stimulated in vitro by a glucomannan-protein preparation of Candida albicans. J Biol Reg Homeost Agents 1:59–68, 1987

    Google Scholar 

  15. Cassone A, Marconi P, Bistoni F, Baccarini M, Garaci E, Mattia E, Bonmassar E: Immunoadjuvant effects of Candida albicans and its cell wall fractions in a mouse lymphoma model. Cancer Immunol Immunother 10:181–190, 1981

    Google Scholar 

  16. Lauro GM, Di Lorenzo N, Grassi M, Maleci A, Guidetti B: Prostaglandin EZ as an immunomodulating factor released in vitro by human glioma cells. Acta Neuropathol 69:278–282, 1986

    Google Scholar 

  17. Ausiello C, Sorrentino V, Ruggiero V, Rossi GB: Action of lysosomatropic amines on spontaneous and interferon-enhanced NK and CTL cytolysis. Immunol Lett 8:11–15, 1984

    Google Scholar 

  18. Stanton GJ, Langford MJ, Dianzani F: Virus yield reduction assay for interferon by titration of Sindbis virus hemagglutinin. Methods Enzymol 78:351–357, 1981

    Google Scholar 

  19. Dianzani F, Monahan TM, Slupham A, Zucca M: Enzymatic induction of interferon production by galactose oxidase treatment of human lymphoid cells. Infect Immun 26:879–882, 1979

    Google Scholar 

  20. Dianzani F, Ramenghi U, Santiano M, Capobianchi MR, Antonelli G: Membrane events leading to interferon-induction by antigens. Proc Soc Exp Biol Med 178:139–142, 1985

    Google Scholar 

  21. Herberman HB: Interferon and cytotoxin effector cells. In: Vilcek J and De Maeyer E (eds). Interferon and immune system. Elsevier-Amsterdam, 1984, pp 61–84.

    Google Scholar 

  22. Fontana A, Hengartener H, De Tribolet N, Weber E: Glioblastoma cells release interleukin 1 and factors inhibiting interleukin-2 mediated effects. J Immunol 132:1837–1846, 1984

    Google Scholar 

  23. Schwyzer M, Fontana A: Partial purification and biochemical characterization of a T cell suppressor factor produced by human glioblastoma cells. J Immunol 134:1003–1009, 1985

    Google Scholar 

  24. Tartof D, Check IJ, Matutis A, Hunter RL, Fitch FW. Studies on stimulation of cell-mediated cytotoxicity by skin test antigens. J Immunol 125:2790–2796, 1980

    Google Scholar 

  25. Tartof D, Curran JS, Levitt D, Loken MR: The skin test antigen stimulated killer (STAK) cell mediating NK-like CMC is OKMI positive and OKT3 negative. Clin Exp Immunol 54:561–566, 1983

    Google Scholar 

  26. Ullen H, Blom U, Blomgren H: Natural killer activity of blood lymphocytes in patients with primary intracranial tumors. Correlation of histological tumor type and anatomical site. Eur J Cancer Clin Oncol 10:1239–1245, 1986

    Google Scholar 

  27. Hahn BH, MacDermott RP, Pletscher SB, Jacobs LS, Beale MG: Immunosuppressive effects of low doses of glucocorticoids: Effects on autologous and allogenic mixed leukocyte reactions. J Immunol 127:2812–2817, 1980

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ausielloh, C., Maleci, A., Spagnolil, G.C. et al. Cell-mediated cytotoxicity in glioma-bearing patients: Differential responses of peripheral blood mononuclear cells to stimulation with interleukin-2 and microbial antigen. J Neuro-Oncol 6, 329–338 (1988). https://doi.org/10.1007/BF00177428

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00177428

Key words

Navigation